BSTC News and Press, BioSpecifics Technologies Corp From 04/09/20

Stock Information

Company Name:	BioSpecifics Technologies Corp
Stock Symbol:	BSTC
Market:	NASDAQ
Website:	biospecifics.com

BSTC BSTC Quote BSTC Short BSTC News BSTC Articles BSTC Message Board

Get BSTC Alerts

News, Short Squeeze, Breakout and More Instantly...

Email Address

BSTC - BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer

WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America...

BSTC - BioSpecifics Tech EPS beats by $0.06, beats on revenue

BioSpecifics Tech (NASDAQ: BSTC ): Q4 GAAP EPS of $1.00 beats by $0.06 . More news on: BioSpecifics Technologies Corp., Earnings news and commentary, Healthcare stocks news, Read more ...

BSTC - BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

WILIMINGTON, Del., March 16, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX ® in North...

BSTC - In Search Of The Best Growth Stocks

Investing in the best growth stocks can generate superior returns over the long term. On the other hand, growth stocks are also particularly volatile and risky. The key, like usually happens, is separating the fundamentally sound companies from the ones with mediocre fundamentals. The follow...

BSTC - BioSpecifics Tech EPS beats by $0.10, beats on revenue

BioSpecifics Tech (NASDAQ: BSTC ): Q3 GAAP EPS of $0.85 beats by $0.10 . More news on: BioSpecifics Technologies Corp., Earnings news and commentary, Healthcare stocks news, Read more ...

BSTC - BioSpecifics Reports Third Quarter 2019 Financial and Operating Results

LYNBROOK, N.Y. , Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. an...

BSTC - 8 Small-Cap Growth At A Reasonable Price Stocks To Consider

Welcome to the Growth at a Reasonable Price screen for November. Generally, growth at a reasonable price is not an investment criterion for value investors, but these screens turn up stocks that can satisfy a stricter value investment filters. That being said, small-cap stocks are more lik...

BSTC - Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

LYNBROOK, N.Y. , Oct. 23, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX ® in the U.S. and Xiapex &...

BSTC - BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer

LYNBROOK, N.Y. , Oct. 10, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX ® in the U.S. and ...

BSTC - Summers Value Partners Q2 2019 Investor Letter